TRANSMEDICS GROUP INC - NOTE 1.500% 6/0

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Debt / NOTE 1.500% 6/0
Market price (% of par)
184.51%
Total 13F principal
$466,705,600
Principal change
+$14,294,600
Total reported market value
$862,026,492
Number of holders
47
Value change
+$28,873,282
Number of buys
18
Number of sells
20

Institutional Holders of TRANSMEDICS GROUP INC - NOTE 1.500% 6/0 as of Q3 2024

As of 30 Sep 2024, TRANSMEDICS GROUP INC - NOTE 1.500% 6/0 was held by 47 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $466,705,600 in principal (par value) of the bond. The largest 10 bondholders included Linden Advisors LP, WOLVERINE ASSET MANAGEMENT LLC, READYSTATE ASSET MANAGEMENT LP, MACKAY SHIELDS LLC, LAZARD ASSET MANAGEMENT LLC, Sculptor Capital LP, D. E. Shaw & Co., Inc., LORD, ABBETT & CO. LLC, Mint Tower Capital Management B.V., and Man Group plc. This page lists 47 institutional bondholders reporting positions for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.